This site has been created solely for the purpose of providing information about services available from Richmond Pharmacology. The site has been compiled in good faith from information available at the time and is therefore subject to change at any time and without notification.
Mission Statement
Our Mission Statement guides our employees, volunteers and stakeholders and outlines our goals and objectives as an organisation.
Richmond Pharmacology Appoints John Hotti as Chief Technology Officer
April 22, 2026
Richmond Pharmacology is pleased to announce the appointment of John Hotti as Chief Technology Officer (CTO), strengthening the company’s leadership in technology-enabled clinical research.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
